LERONLIMAB IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: RESULTS FROM NASH01 METABOLIC AND IMMUNOMODULATORY MECHANISMS OF ACTION

Noureddin, M; Lawitz, EJ; Ritter, A; Hassanein, TI; Kelly, S; Meidling, J; Hansen, S; Recknor, C

HEPATOLOGY, 2022; 76 (): S710